Expect EPS upgrades valuation rerating for Aurobindo: Surajit Pal News News / News 6 years ago 475 Views comments Aurobindo Pharma has gotten the United States Foods and Drug Administration (USFDA) approval for a generic drug that treats a chronic kidney disease.... Read more
News J&K police's heartfelt message to the daughter of the martyred Kashmiri cop News / News - 6 years ago
News This bull market making a mockery of doomsayers! 5 stocks which can give up to 14% return News / News - 6 years ago
Comments